RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0038-1653678
An Accelerated Red-Cell Hemagglutination Inhibition Immunoassay for Measuring Fibrinogen Degradation Products in Human Serum
This work was supported in part by research grant 3.102.69 from the Swiss National Foundation. The skillful technical assistance of Miss C. Lynch is gratefully acknowledged
Publikationsverlauf
Publikationsdatum:
24. Juli 2018 (online)
Summary
A further modification of Merskey’s hemagglutination inhibition assay for measurement of fibrinogen degradation products (FDP) in human serum was developed. Blood is clotted in the presence of protamine chloride (25 u/ml), in addition to thrombin and s-aminocaproic acid, and at room temperature. Defibrination is complete within 5 min even in blood obtained from patients on heparin treatment. The hemagglutination immunoassay was also considerably accelerated by immediate addition of sensitized red cells to the mixtures of antiserum and antigen dilutions at 37° C. Accurate readings of FDP titers may thus be obtained within 20 min following venipuncture.
* Address requests for reprints to: Prof. E. A. Beck, Hamatologisches Zentrallabor, Inselspital, CH-3008 Bern, Switzerland.
-
References
- 1 Derechin M. Caractères généraux de la paracoagulation fibrinoly tique. Rev. Hémat 10: 35 1955;
- 2 Marder V. J, Shulman N. R. High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. J. Biol. Chem 244: 2120 1969;
- 3 Marder V. J, Shulman N. R, Carroll W. R. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunochemical characterization. J. Biol. Chem 244: 2111 1969;
- 4 Merskey C, Kleiner G. J, Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood 28: 1 1966;
- 5 Merskey G, Lalezari P, Johnson A. J. A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum. Proc. Soc. exp. Biol. (N. Y) 131: 871 1969;
- 6 Thomas D. P, Niewiarowski S, Myers A. R, Bloch K. J, Colman R. W. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. New Engl. J. Med 283: 663 1970;
- 7 Triantaphyllopoulos D. C. Anticoagulant effect of incubated fibrinogen. Canad. J. Biochem 36: 250 1958;